ribavirin has been researched along with Androgen-Independent Prostatic Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimura, T; Hongo, H; Inoue, S; Kosaka, T; Oya, M; Suzuki, T; Suzuki, Y; Takayama, KI | 1 |
| Horimoto, K; Kosaka, T; Nagamatsu, G; Oya, M; Saito, S; Suda, T | 1 |
2 other study(ies) available for ribavirin and Androgen-Independent Prostatic Cancer
| Article | Year |
|---|---|
Subtype-specific collaborative transcription factor networks are promoted by OCT4 in the progression of prostate cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Resistance, Neoplasm; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; HEK293 Cells; Hepatocyte Nuclear Factor 3-alpha; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nuclear Respiratory Factor 1; Octamer Transcription Factor-3; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Ribavirin; Signal Transduction; Transcriptome | 2021 |
Identification of drug candidate against prostate cancer from the aspect of somatic cell reprogramming.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cellular Reprogramming; Docetaxel; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Male; Mice; Mice, Nude; Octamer Transcription Factor-3; Prostatic Neoplasms, Castration-Resistant; Ribavirin; SOXB1 Transcription Factors; Taxoids; Xenograft Model Antitumor Assays | 2013 |